The top venture-capital investors in the psychedelics industry

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 51 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 51%

日本 ニュース ニュース

Meet the top 10 psychedelics VCs who’ve bet the most cash on turning MDMA and magic mushrooms into medicines for anxiety and depression

from private investors over the past year, and many have gone public.

We reached out to 18 investment firms focused on private psychedelics companies and asked them about their total deal count, assets under management, and how much funding they've invested in startups in the industry. Since the for-profit psychedelics space has been around for only a few years, most of these firms were founded recently. We narrowed our list to 10 firms based on how much they've invested in startups over the past few years. The 10 firms have invested about $79 million altogether.

Insider used data from PitchBook, CB Insights, and PsyIndex. We also asked sources within psychedelics which firms have been most heavily involved. We didn't include investment firms that focus primarily on other industries or wealthy individuals like Peter Thiel or Michael Novogratz who have heavily invested their own cash. We also left out Christian Angermayer and his firm, Apeiron Investment Group, both of which have invested heavily in psychedelics but focus on other sectors.

 

コメントありがとうございます。コメントは審査後に公開されます。

Always about who can scam the most fucking money out of people. Can we ever just have anything good without capitalists destroying it?

The future

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 729. in JP

日本 最新ニュース, 日本 見出し